Number of studies: k = 12
Number of treatments: n = 9
Number of pairwise comparisons: m = 12
Number of designs: d = 8

Fixed effects model

Treatment estimate (sm = 'OR'):
             daridorexant eszopiclone lemborexant melatonin placebo ramelteon suvorexant zolpidem zopiclone
daridorexant            .      1.4986      0.7639    0.3041  1.0002    0.6378     1.1031   1.5880    1.1368
eszopiclone        0.6673           .      0.5098    0.2029  0.6674    0.4256     0.7361   1.0596    0.7585
lemborexant        1.3090      1.9617           .    0.3980  1.3093    0.8350     1.4440   2.0787    1.4881
melatonin          3.2888      4.9286      2.5124         .  3.2895    2.0977     3.6278   5.2225    3.7386
placebo            0.9998      1.4983      0.7637    0.3040       .    0.6377     1.1028   1.5876    1.1365
ramelteon          1.5678      2.3495      1.1977    0.4767  1.5681         .     1.7294   2.4896    1.7822
suvorexant         0.9066      1.3586      0.6925    0.2756  0.9068    0.5782          .   1.4396    1.0305
zolpidem           0.6297      0.9437      0.4811    0.1915  0.6299    0.4017     0.6947        .    0.7159
zopiclone          0.8797      1.3183      0.6720    0.2675  0.8799    0.5611     0.9704   1.3969         .

Lower 95%-confidence limit:
             daridorexant eszopiclone lemborexant melatonin placebo ramelteon suvorexant zolpidem zopiclone
daridorexant            .      0.9753      0.4660    0.1783  0.6906    0.3624     0.6653   1.0159    0.5450
eszopiclone        0.4343           .      0.3441    0.1304  0.5370    0.2635     0.4900   0.7611    0.4177
lemborexant        0.7985      1.3244           .    0.2402  0.9439    0.4875     0.8982   1.3775    0.7284
melatonin          1.9282      3.1688      1.5164         .  2.2395    1.1807     2.1656   3.3023    1.7795
placebo            0.6903      1.2055      0.5506    0.2070       .    0.4160     0.7818   1.2371    0.6022
ramelteon          0.8906      1.4548      0.6992    0.2683  1.0229         .     0.9993   1.5180    0.8290
suvorexant         0.5468      0.9044      0.4308    0.1645  0.6428    0.3341          .   0.9412    0.5005
zolpidem           0.4029      0.6778      0.3188    0.1211  0.4908    0.2449     0.4542        .    0.3618
zopiclone          0.4217      0.7259      0.3289    0.1273  0.4663    0.2610     0.4713   0.7061         .

Upper 95%-confidence limit:
             daridorexant eszopiclone lemborexant melatonin placebo ramelteon suvorexant zolpidem zopiclone
daridorexant            .      2.3027      1.2523    0.5186  1.4487    1.1228     1.8288   2.4821    2.3712
eszopiclone        1.0253           .      0.7550    0.3156  0.8295    0.6874     1.1057   1.4753    1.3776
lemborexant        2.1459      2.9057           .    0.6594  1.8162    1.4301     2.3214   3.1369    3.0401
melatonin          5.6095      7.6658      4.1625         .  4.8319    3.7271     6.0772   8.2592    7.8546
placebo            1.4481      1.8621      1.0594    0.4465       .    0.9776     1.5556   2.0375    2.1448
ramelteon          2.7597      3.7945      2.0513    0.8470  2.4039         .     2.9930   4.0831    3.8314
suvorexant         1.5030      2.0409      1.1133    0.4618  1.2790    1.0007          .   2.2018    2.1219
zolpidem           0.9843      1.3139      0.7259    0.3028  0.8084    0.6588     1.0625        .    1.4163
zopiclone          1.8350      2.3942      1.3729    0.5620  1.6605    1.2063     1.9981   2.7638         .

Random effects model

Treatment estimate (sm = 'OR'):
             daridorexant eszopiclone lemborexant melatonin placebo ramelteon suvorexant zolpidem zopiclone
daridorexant            .      1.4987      0.7757    0.3087  1.0156    0.6477     1.1260   1.5276    1.1368
eszopiclone        0.6672           .      0.5176    0.2060  0.6777    0.4322     0.7513   1.0192    0.7585
lemborexant        1.2892      1.9321           .    0.3980  1.3093    0.8350     1.4517   1.9693    1.4656
melatonin          3.2389      4.8542      2.5124         .  3.2895    2.0977     3.6471   4.9476    3.6821
placebo            0.9846      1.4756      0.7637    0.3040       .    0.6377     1.1087   1.5040    1.1193
ramelteon          1.5440      2.3140      1.1977    0.4767  1.5681         .     1.7386   2.3585    1.7553
suvorexant         0.8881      1.3310      0.6889    0.2742  0.9020    0.5752          .   1.3566    1.0096
zolpidem           0.6546      0.9811      0.5078    0.2021  0.6649    0.4240     0.7371        .    0.7442
zopiclone          0.8796      1.3183      0.6823    0.2716  0.8934    0.5697     0.9905   1.3437         .

Lower 95%-confidence limit:
             daridorexant eszopiclone lemborexant melatonin placebo ramelteon suvorexant zolpidem zopiclone
daridorexant            .      0.8422      0.3924    0.1517  0.6411    0.3106     0.5965   0.8250    0.4561
eszopiclone        0.3750           .      0.2809    0.1082  0.4789    0.2212     0.4295   0.5957    0.3735
lemborexant        0.6521      1.0488           .    0.1901  0.7919    0.3896     0.7451   1.0295    0.5751
melatonin          1.5911      2.5506      1.1997         .  1.9135    0.9534     1.8167   2.5082    1.4141
placebo            0.6215      1.0428      0.4619    0.1768       .    0.3596     0.7153   0.9984    0.5086
ramelteon          0.7405      1.1842      0.5588    0.2167  0.8842         .     0.8451   1.1661    0.6621
suvorexant         0.4704      0.7609      0.3536    0.1366  0.5819    0.2796          .   0.7445    0.4095
zolpidem           0.3535      0.5734      0.2655    0.1025  0.4413    0.2096     0.4045        .    0.3059
zopiclone          0.3529      0.6492      0.2677    0.1043  0.4059    0.2149     0.4017   0.5524         .

Upper 95%-confidence limit:
             daridorexant eszopiclone lemborexant melatonin placebo ramelteon suvorexant zolpidem zopiclone
daridorexant            .      2.6670      1.5334    0.6285  1.6089    1.3504     2.1257   2.8286    2.8334
eszopiclone        1.1874           .      0.9535    0.3921  0.9589    0.8444     1.3142   1.7439    1.5403
lemborexant        2.5485      3.5594           .    0.8335  2.1648    1.7894     2.8284   3.7671    3.7349
melatonin          6.5930      9.2381      5.2614         .  5.6551    4.6154     7.3216   9.7594    9.5878
placebo            1.5598      2.0881      1.2627    0.5226       .    1.1309     1.7185   2.2658    2.4635
ramelteon          3.2192      4.5216      2.5667    1.0488  2.7810         .     3.5766   4.7704    4.6533
suvorexant         1.6765      2.3280      1.3422    0.5504  1.3981    1.1833          .   2.4719    2.4893
zolpidem           1.2122      1.6787      0.9714    0.3987  1.0016    0.8576     1.3432        .    1.8104
zopiclone          2.1923      2.6771      1.7388    0.7072  1.9662    1.5103     2.4422   3.2686         .

Quantifying heterogeneity / inconsistency:
tau^2 = 0.0379; tau = 0.1948; I^2 = 43.3% [0.0%; 79.2%]

Tests of heterogeneity (within designs) and inconsistency (between designs):
                   Q d.f. p-value
Total           7.06    4  0.1328
Within designs  7.06    4  0.1328
Between designs 0.00    0      --
[1] "A total of 9 treatments are included in the network."
[1] "A total of 12 studies are included in this analysis."
[1] "A total of 8042 participants are included in this analysis, with 1948 events (24.22%)."
[1] "The following studies were included in this analysis: 45 46 58 59 75 106 112 130 136 155 159 160"
[1] "Estimated heterogeneity tau-squared0.04"
[1] "Global test for inconsistency, p-value NA (Q=0, d.o.f. 0)"
[1] "File created on 2022-01-25"
